Your browser doesn't support javascript.
loading
A microRNA Cluster Controls Fat Cell Differentiation and Adipose Tissue Expansion By Regulating SNCG.
Rodríguez-Barrueco, Ruth; Latorre, Jessica; Devis-Jáuregui, Laura; Lluch, Aina; Bonifaci, Nuria; Llobet, Francisco J; Olivan, Mireia; Coll-Iglesias, Laura; Gassner, Katja; Davis, Meredith L; Moreno-Navarrete, José M; Castells-Nobau, Anna; Plata-Peña, Laura; Dalmau-Pastor, Miki; Höring, Marcus; Liebisch, Gerhard; Olkkonen, Vesa M; Arnoriaga-Rodríguez, Maria; Ricart, Wifredo; Fernández-Real, José M; Silva, José M; Ortega, Francisco J; Llobet-Navas, David.
Afiliação
  • Rodríguez-Barrueco R; Molecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908, Spain.
  • Latorre J; Anatomy Unit, Department of Pathology and Experimental Therapy, School of Medicine, University of Barcelona (UB), L'Hospitalet de Llobregat, 08907, Spain.
  • Devis-Jáuregui L; Department of Diabetes, Endocrinology, and Nutrition (UDEN), Institut d'Investigació Biomèdica de Girona (IDIBGI), Salt, 17190, Spain.
  • Lluch A; Centro de Investigación Biomédica en Red de la Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
  • Bonifaci N; Molecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908, Spain.
  • Llobet FJ; Molecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908, Spain.
  • Olivan M; Department of Diabetes, Endocrinology, and Nutrition (UDEN), Institut d'Investigació Biomèdica de Girona (IDIBGI), Salt, 17190, Spain.
  • Coll-Iglesias L; Molecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908, Spain.
  • Gassner K; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, (ISCIII), Madrid, 28029, Spain.
  • Davis ML; Molecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908, Spain.
  • Moreno-Navarrete JM; Molecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908, Spain.
  • Castells-Nobau A; Anatomy Unit, Department of Pathology and Experimental Therapy, School of Medicine, University of Barcelona (UB), L'Hospitalet de Llobregat, 08907, Spain.
  • Plata-Peña L; Molecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908, Spain.
  • Dalmau-Pastor M; Molecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908, Spain.
  • Höring M; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, (ISCIII), Madrid, 28029, Spain.
  • Liebisch G; Molecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908, Spain.
  • Olkkonen VM; Department of Pathology, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Arnoriaga-Rodríguez M; Department of Diabetes, Endocrinology, and Nutrition (UDEN), Institut d'Investigació Biomèdica de Girona (IDIBGI), Salt, 17190, Spain.
  • Ricart W; Centro de Investigación Biomédica en Red de la Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
  • Fernández-Real JM; Department of Diabetes, Endocrinology, and Nutrition (UDEN), Institut d'Investigació Biomèdica de Girona (IDIBGI), Salt, 17190, Spain.
  • Silva JM; Molecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908, Spain.
  • Ortega FJ; Anatomy Unit, Department of Pathology and Experimental Therapy, School of Medicine, University of Barcelona (UB), L'Hospitalet de Llobregat, 08907, Spain.
  • Llobet-Navas D; MIFAS by GRECMIP (Minimally Invasive Foot and Ankle Society), Merignac, 33700, France.
Adv Sci (Weinh) ; 9(4): e2104759, 2022 02.
Article em En | MEDLINE | ID: mdl-34898027
ABSTRACT
The H19X-encoded miR-424(322)/503 cluster regulates multiple cellular functions. Here, it is reported for the first time that it is also a critical linchpin of fat mass expansion. Deletion of this miRNA cluster in mice results in obesity, while increasing the pool of early adipocyte progenitors and hypertrophied adipocytes. Complementary loss and gain of function experiments and RNA sequencing demonstrate that miR-424(322)/503 regulates a conserved genetic program involved in the differentiation and commitment of white adipocytes. Mechanistically, it is demonstrated that miR-424(322)/503 targets γ-Synuclein (SNCG), a factor that mediates this program rearrangement by controlling metabolic functions in fat cells, allowing adipocyte differentiation and adipose tissue enlargement. Accordingly, diminished miR-424(322) in mice and obese humans co-segregate with increased SNCG in fat and peripheral blood as mutually exclusive features of obesity, being normalized upon weight loss. The data unveil a previously unknown regulatory mechanism of fat mass expansion tightly controlled by the miR-424(322)/503 through SNCG.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diferenciação Celular / Tecido Adiposo / MicroRNAs / Gama-Sinucleína / Proteínas de Neoplasias Limite: Animals / Female / Humans / Male Idioma: En Revista: Adv Sci (Weinh) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diferenciação Celular / Tecido Adiposo / MicroRNAs / Gama-Sinucleína / Proteínas de Neoplasias Limite: Animals / Female / Humans / Male Idioma: En Revista: Adv Sci (Weinh) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha